Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 92,154	$ 656,203
Accounts receivable, net	129,122	115,458
Prepaid expenses and other current assets	12,012	7,715
Restricted cash		1,250
Total current assets	233,288	780,626
Restricted cash, net of current portion		485
Accounts receivable, net of current portion		14,589
Property and equipment, net	5,585	6,288
Operating lease right-of-use assets	12,586	14,023
Intangible assets, net	3,682
Deferred tax assets	212,324	283,661
Other assets	3,608	847
Total assets	471,073	1,100,519
Current liabilities:
Accounts payable	7,830	483
Accrued research and development costs	21,331	5,258
Accrued expenses and other current liabilities	44,254	16,700
Current portion of operating lease liabilities	3,126	3,065
Current portion of convertible senior notes	199,560
Note hedge warrants		19
Total current liabilities	276,101	25,525
Convertible senior notes, net of current portion	198,309	396,251
Operating lease obligations, net of current portion	14,543	16,599
Revolving credit facility	300,000
Other liabilities	28,415	9,766
Commitments and contingencies
Stockholders' equity (deficit):
Preferred stock, $0.001 par value, 75,000,000 shares authorized, no shares issued and outstanding
Class A Common Stock, $0.001 par value, 500,000,000 shares authorized and 156,354,238 shares issued and outstanding at December 31, 2023 and 500,000,000 shares authorized and 154,026,949 shares issued and outstanding at December 31, 2022	156	154
Additional paid-in capital	1,355,195	1,348,600
Accumulated deficit	(1,698,615)	(696,376)
Accumulated other comprehensive loss	(3,031)
Total stockholders' equity (deficit)	(346,295)	652,378
Total liabilities and stockholders' equity	$ 471,073	$ 1,100,519